{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:57:34Z","timestamp":1790485054756,"version":"4.1.0"},"reference-count":68,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Universidad de las Am\u00e9ricas","award":["592.A.XVII.25"],"award-info":[{"award-number":["592.A.XVII.25"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Glioblastoma (GBM) remains one of the most lethal and intractable central nervous system malignancies, characterized by aggressive cellular proliferation, profound hypoxia, and an immunosuppressive microenvironment. The primary pharmacokinetic obstacle for systemic interventions is the blood\u2013brain barrier (BBB), which restricts the infiltration of free therapeutic agents. To overcome this limitation, translational nanomedicine has driven the design of next-generation delivery systems, including liposomal vectors and synthetic organic, inorganic, and hybrid nanoparticles. This study establishes an exhaustive analysis of molecular targeting strategies designed to actively hijack physiological transport pathways via receptor-mediated transcytosis (RMT) targeting transferrin, lactoferrin, and LRP1 receptors and adsorption-mediated transcytosis (AMT) using polycationic biomaterials. Terminal selectivity via tumor-specific antigens, such as EGFRvIII and nucleolin (targeted by the AS1411 aptamer), is also discussed alongside smart stimuli-responsive platforms that exploit the tumor microenvironment\u2019s acidic pH, hypoxia, and matrix metalloproteinase activity for localized drug release. Concurrently, the deployment of these nanoplatforms for the intracellular vectorization of advanced genetic material, including siRNA (targeting VEGF and MGMT) and CRISPR\/Cas9 complexes, demonstrates significant efficacy in reversing genomic chemoresistance and collapsing tumor neoangiogenesis. Finally, the review addresses critical bioengineering and clinical bottlenecks such as manufacturing scale-up, human BBB complexity, opsonization, and the long-term toxicity of inorganic nanoparticles that currently limit the regulatory transition of these highly promising neuro-oncological nanotechnologies from bench to bedside.<\/jats:p>","DOI":"10.3390\/ijms27198564","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:09:02Z","timestamp":1790323742000},"page":"8564","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Next-Generation Liposomal and Nanoparticle-Based Systems for Glioblastoma: Molecular Targeting Strategies to Overcome the Blood\u2013Brain Barrier"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7390-6625","authenticated-orcid":false,"given":"Joaquin","family":"Fiallo Arroyo","sequence":"first","affiliation":[{"name":"Escuela de Medicina, Universidad de Las Am\u00e9ricas, Quito 170125, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6595-8703","authenticated-orcid":false,"given":"Bernardo","family":"Castell\u00f3n","sequence":"additional","affiliation":[{"name":"Escuela de Medicina, Universidad de Las Am\u00e9ricas, Quito 170125, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8130-6460","authenticated-orcid":false,"given":"Jose E.","family":"Leon-Rojas","sequence":"additional","affiliation":[{"name":"Escuela de Medicina, Universidad de Las Am\u00e9ricas, Quito 170125, Ecuador"},{"name":"Grupo de Investigaci\u00f3n Bienestar, Salud y Sociedad, Escuela de Psicolog\u00eda y Educaci\u00f3n, Universidad de Las Am\u00e9ricas, Quito 170125, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Bartusik-Aebisher, D., Rog\u00f3\u017c, K., and Aebisher, D. (2025). Nanoparticles for Glioblastoma Treatment. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17060688"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.2147\/IJN.S470478","article-title":"Liposomal Nanomaterials: A Rising Star in Glioma Treatment","volume":"19","author":"Gan","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Ramalho, M.J., Loureiro, J.A., Coelho, M.A.N., and Pereira, M.C. (2022). Transferrin Receptor-Targeted Nanocarriers: Overcoming Barriers to Treat Glioblastoma. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14020279"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s13346-022-01245-z","article-title":"Transferrin-Modified Chitosan Nanoparticles for Targeted Nose-to-Brain Delivery of Proteins","volume":"13","author":"Gabold","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"100671","DOI":"10.1016\/j.mtbio.2023.100671","article-title":"A Receptor-Mediated Landscape of Druggable and Targeted Nanomaterials for Gliomas","volume":"20","author":"Duarte","year":"2023","journal-title":"Mater. Today Bio"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1007\/s10072-025-08457-4","article-title":"Advancing Glioblastoma Therapy with Surface-Modified Nanoparticles","volume":"46","author":"Zeppieri","year":"2025","journal-title":"Neurol. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e2118697119","DOI":"10.1073\/pnas.2118697119","article-title":"A Predictive Microfluidic Model of Human Glioblastoma to Assess Trafficking of Blood-Brain Barrier-Penetrant Nanoparticles","volume":"119","author":"Straehla","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"101122","DOI":"10.1016\/j.drup.2024.101122","article-title":"Framework Nucleic Acid-Based Nanoparticles Enhance Temozolomide Sensitivity in Glioblastoma","volume":"76","author":"Lan","year":"2024","journal-title":"Drug Resist. Updat."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"100076","DOI":"10.1016\/j.pharmr.2025.100076","article-title":"Cracking the EGFR Code: Cancer Biology, Resistance Mechanisms, and Future Therapeutic Frontiers","volume":"77","author":"Du","year":"2025","journal-title":"Pharmacol. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"eaaa0984","DOI":"10.1126\/scitranslmed.aaa0984","article-title":"A Single Dose of Peripherally Infused EGFRvIII-Directed CAR T Cells Mediates Antigen Loss and Induces Adaptive Resistance in Patients with Recurrent Glioblastoma","volume":"9","author":"Nasrallah","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"eabe7378","DOI":"10.1126\/scitranslmed.abe7378","article-title":"SynNotch-CAR T Cells Overcome Challenges of Specificity, Heterogeneity, and Persistence in Treating Glioblastoma","volume":"13","author":"Choe","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41591-024-02893-z","article-title":"Intrathecal Bivalent CAR T Cells Targeting EGFR and IL13R\u03b12 in Recurrent Glioblastoma: Phase 1 Trial Interim Results","volume":"30","author":"Bagley","year":"2024","journal-title":"Nat. Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Seo, K., Hwang, K., Nam, K.M., Kim, M.J., Song, Y.-K., and Kim, C.-Y. (2024). Nucleolin-Targeting AS1411 Aptamer-Conjugated Nanospheres for Targeted Treatment of Glioblastoma. Pharmaceutics, 16.","DOI":"10.20944\/preprints202404.0167.v1"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1039\/C6TB03365B","article-title":"Nucleolin-Targeted Selenium Nanocomposites with Enhanced Theranostic Efficacy to Antagonize Glioblastoma","volume":"5","author":"He","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"110770","DOI":"10.1016\/j.colsurfb.2019.110770","article-title":"PEGylated Nanocarriers: A Promising Tool for Targeted Delivery to the Brain","volume":"187","author":"Gajbhiye","year":"2020","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_16","first-page":"1","article-title":"Liposomal Nanotherapeutics for Cancer Treatment: Targeted Delivery and Immunotherapy","volume":"40","author":"Tariq","year":"2026","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"114904","DOI":"10.1016\/j.colsurfb.2025.114904","article-title":"Smart Liposomal Systems for Brain Cancer: Technological Innovations in Drug Delivery","volume":"255","author":"Zuberi","year":"2025","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2165\/00003088-200140070-00005","article-title":"Pegylation: A Novel Process for Modifying Pharmacokinetics","volume":"40","author":"Harris","year":"2001","journal-title":"Clin. Pharmacokinet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a Strategy for Improving Nanoparticle-Based Drug and Gene Delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2014.06.046","article-title":"PEG\u2014A Versatile Conjugating Ligand for Drugs and Drug Delivery Systems","volume":"192","author":"Kolate","year":"2014","journal-title":"J. Control. Release"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jconrel.2018.03.006","article-title":"Transferrin-Targeted, Resveratrol-Loaded Liposomes for the Treatment of Glioblastoma","volume":"277","author":"Jhaveri","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11060-020-03408-9","article-title":"Convection-enhanced Drug Delivery for Glioblastoma: A Review","volume":"151","author":"Aghi","year":"2021","journal-title":"J. Neurooncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1007\/s13346-020-00773-w","article-title":"Convection-Enhanced Delivery of Liposomal Drugs for Effective Treatment of Glioblastoma Multiforme","volume":"10","author":"Han","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3892\/mco.2014.356","article-title":"Passive Targeting of Nanoparticles to Cancer: A Comprehensive Review of the Literature","volume":"2","author":"Bazak","year":"2014","journal-title":"Mol. Clin. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12935-022-02687-8","article-title":"Multimodal Targeting of Glioma with Functionalized Nanoparticles","volume":"22","author":"Marei","year":"2022","journal-title":"Cancer Cell Int."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jconrel.2022.07.027","article-title":"MicroRNA Delivery Systems in Glioma Therapy and Perspectives: A Systematic Review","volume":"349","author":"Orozco","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jconrel.2024.10.037","article-title":"Recent Advances in Liposomes and Peptide-Based Therapeutics for Glioblastoma Treatment","volume":"376","author":"Jourdain","year":"2024","journal-title":"J. Control. Release"},{"key":"ref_28","first-page":"1658","article-title":"Transferrin and Cell-Penetrating Peptide Dual-Functioned Liposome for Targeted Drug Delivery to Glioma","volume":"8","author":"Zheng","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jconrel.2019.06.033","article-title":"Dual Functionalized Liposomes for Efficient Co-Delivery of Anti-Cancer Chemotherapeutics for the Treatment of Glioblastoma","volume":"307","author":"Lakkadwala","year":"2019","journal-title":"J. Control. Release"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Riaz, M.K., Riaz, M.A., Zhang, X., Lin, C., Wong, K.H., Chen, X., Zhang, G., Lu, A., and Yang, Z. (2018). Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19010195"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13205-020-2144-3","article-title":"Recent Strategies towards the Surface Modification of Liposomes: An Innovative Approach for Different Clinical Applications","volume":"10","author":"Khan","year":"2020","journal-title":"3 Biotech"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s10517-017-3750-x","article-title":"Internalization of Vectorized Liposomes Loaded with Plasmid DNA in C6 Glioma Cells","volume":"163","author":"Baklaushev","year":"2017","journal-title":"Bull. Exp. Biol. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1021\/bc060174r","article-title":"Synthesis of Cetuximab-Immunoliposomes via a Cholesterol-Based Membrane Anchor for Targeting of EGFR","volume":"18","author":"Pan","year":"2007","journal-title":"Bioconj. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Jose, G., Lu, Y.-J., Hung, J.-T., Yu, A.L., and Chen, J.-P. (2020). Co-Delivery of CPT-11 and Panobinostat with Anti-GD2 Antibody Conjugated Immunoliposomes for Targeted Combination Chemotherapy. Cancers, 12.","DOI":"10.3390\/cancers12113211"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"100365","DOI":"10.1016\/j.esmoop.2021.100365","article-title":"Targeting Immunoliposomes to EGFR-Positive Glioblastoma","volume":"7","author":"Kasenda","year":"2022","journal-title":"ESMO Open"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4155\/tde-2021-0086","article-title":"Novel Therapeutics and Drug-Delivery Approaches in the Modulation of Glioblastoma Stem Cell Resistance","volume":"13","author":"Smiley","year":"2022","journal-title":"Ther. Deliv."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Cesarini, V., Scopa, C., Silvestris, D.A., Scafidi, A., Petrera, V., Del Baldo, G., and Gallo, A. (2020). Aptamer-Based In Vivo Therapeutic Targeting of Glioblastoma. Molecules, 25.","DOI":"10.3390\/molecules25184267"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jconrel.2020.09.055","article-title":"Peptide-Functionalized Liposomes as Therapeutic and Diagnostic Tools for Cancer Treatment","volume":"329","author":"Sonju","year":"2021","journal-title":"J. Control. Release"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1007\/s13346-023-01456-y","article-title":"Local Delivery of Doxorubicin Prodrug via Lipid Nanocapsule\u2013Based Hydrogel for the Treatment of Glioblastoma","volume":"14","author":"Wang","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"66889","DOI":"10.18632\/oncotarget.17976","article-title":"Multifunctional Targeted Liposomal Drug Delivery for Efficient Glioblastoma Treatment","volume":"8","author":"Belhadj","year":"2017","journal-title":"Oncotarget"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Ghaferi, M., Raza, A., Koohi, M., Zahra, W., Akbarzadeh, A., Ebrahimi Shahmabadi, H., and Alavi, S.E. (2022). Impact of PEGylated Liposomal Doxorubicin and Carboplatin Combination on Glioblastoma. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14102183"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"46697","DOI":"10.1021\/acsami.3c10364","article-title":"Doxorubicin-Loaded Liposome with the Function of \u201cKilling Two Birds with One Stone\u201d against Glioma","volume":"15","author":"Cen","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1080\/10717544.2021.1938756","article-title":"PLGA-Based Biodegradable Microspheres in Drug Delivery: Recent Advances in Research and Application","volume":"28","author":"Su","year":"2021","journal-title":"Drug Deliv."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"125969","DOI":"10.1016\/j.ijpharm.2025.125969","article-title":"Advances in Nanoparticle Systems for Targeted Therapy against Glioblastoma Multiforme","volume":"682","author":"Riccobelli","year":"2025","journal-title":"Int. J. Pharm."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2147\/IJN.S142079","article-title":"Micelle-Templated, Poly(Lactic-Co-Glycolic Acid) Nanoparticles for Hydrophobic Drug Delivery","volume":"13","author":"Nabar","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"16125","DOI":"10.2147\/IJN.S563730","article-title":"Advances in PLGA-Based Drug Delivery Systems for Glioblastoma Treatment","volume":"20","author":"Roy","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Rahman, M.A., Jalouli, M., Yadab, M.K., and Al-Zharani, M. (2025). Progress in Drug Delivery Systems Based on Nanoparticles for Improved Glioblastoma Therapy: Addressing Challenges and Investigating Opportunities. Cancers, 17.","DOI":"10.3390\/cancers17040701"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Mahmoud, B.S., AlAmri, A.H., and McConville, C. (2020). Polymeric Nanoparticles for the Treatment of Malignant Gliomas. Cancers, 12.","DOI":"10.3390\/cancers12010175"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Roque, D., Cruz, N., Ferreira, H.A., Reis, C.P., Matela, N., Herculano-Carvalho, M., Casc\u00e3o, R., and Faria, C.C. (2023). Nanoparticle-Based Treatment in Glioblastoma. J. Pers. Med., 13.","DOI":"10.3390\/jpm13091328"},{"key":"ref_50","first-page":"567931","article-title":"Clinical Applications and Future Prospects of Metallic Nanoparticles in Diagnosis and Therapy","volume":"21","author":"Romero","year":"2026","journal-title":"Int. J. Nanomed."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Dynarowicz, K., Aebisher, D., Tylutki, J., Kozak, N., Kawczyk-Krupka, A., and Bartusik-Aebisher, D. (2026). Small Particles, Big Impact: Inorganic Nanotechnology for Glioblastoma. Molecules, 31.","DOI":"10.3390\/molecules31030565"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.2147\/IJN.S378217","article-title":"PDA-Based Drug Delivery Nanosystems: A Potential Approach for Glioma Treatment","volume":"17","author":"Wu","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.addr.2018.10.013","article-title":"Approaches to Physical Stimulation of Metallic Nanoparticles for Glioblastoma Treatment","volume":"138","author":"Pinel","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"100673","DOI":"10.1016\/j.mtbio.2023.100673","article-title":"Challenges and Advances for Glioma Therapy Based on Inorganic Nanoparticles","volume":"20","author":"Hu","year":"2023","journal-title":"Mater. Today Bio"},{"key":"ref_55","first-page":"2863","article-title":"Nanoparticles for Hyperthermic Therapy: Synthesis Strategies and Applications in Glioblastoma","volume":"9","author":"Verma","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/20415990.2025.2484170","article-title":"Engineered Nanoparticles as a Promising Drug Delivery System for Glioblastoma Multiforme Treatment","volume":"16","author":"Zarneshan","year":"2025","journal-title":"Ther. Deliv."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Matsuo-Tani, A., Matsumoto, M., Hiu, T., Kamiya, M., Geng, L., Takayama, R., Ushiroda, Y., Kato, N., Nakamura, H., and Yoshida, M. (2025). Targeted Delivery of VEGF-siRNA to Glioblastoma Using Orientation-Controlled Anti-PD-L1 Antibody-Modified Lipid Nanoparticles. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17101298"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"eabc9450","DOI":"10.1126\/sciadv.abc9450","article-title":"CRISPR-Cas9 Genome Editing Using Targeted Lipid Nanoparticles for Cancer Therapy","volume":"6","author":"Rosenblum","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Horta, M., Soares, P., Leite Pereira, C., and Lima, R.T. (2025). Emerging Approaches in Glioblastoma Treatment: Modulating the Extracellular Matrix Through Nanotechnology. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17020142"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"7672","DOI":"10.1038\/s41467-025-63081-2","article-title":"Bioengineered Hybrid Dual-Targeting Nanoparticles Reprogram the Tumour Microenvironment for Deep Glioblastoma Photodynamic Therapy","volume":"16","author":"Zhao","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_61","first-page":"3742","article-title":"Extracellular Matrix in Glioblastoma: Opportunities for Emerging Therapeutic Approaches","volume":"11","author":"Mohiuddin","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Wang, B., Li, C., Gu, J., Wang, X., Xun, M., Jiang, B., and Yan, J. (2025). Targeting Glioma-Associated Microglia and Macrophages: A New Frontier in Glioblastoma Immunotherapy. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1726440"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1802070","DOI":"10.1002\/advs.201802070","article-title":"Therapeutic Remodeling of the Tumor Microenvironment Enhances Nanoparticle Delivery","volume":"6","author":"Chen","year":"2019","journal-title":"Adv. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"14499","DOI":"10.2147\/IJN.S547510","article-title":"Nano-Drug Delivery Systems Targeting MMPs: A Promising Treatment for Gliomas","volume":"20","author":"Liu","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s11095-016-1947-8","article-title":"Nanoparticles for Targeting Intratumoral Hypoxia: Exploiting a Potential Weakness of Glioblastoma","volume":"33","author":"Aldea","year":"2016","journal-title":"Pharm. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.7150\/thno.26225","article-title":"Hypoxia-Responsive Lipid-Poly-(Hypoxic Radiosensitized Polyprodrug) Nanoparticles for Glioma Chemo- and Radiotherapy","volume":"8","author":"Hua","year":"2018","journal-title":"Theranostics"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Messina, S., Zuchegna, C., and Bruzzi, M. (2025). Chemotherapeutic Nanoparticles for Glioblastoma. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1641752"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3892\/ijo.2025.5789","article-title":"Nanoparticle-Based Delivery Systems for Targeted Therapy in Brain Tumors: Progress, Challenges and Perspectives (Review)","volume":"67","author":"Si","year":"2025","journal-title":"Int. J. Oncol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8564\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:11:23Z","timestamp":1790482283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":68,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["ijms27198564"],"URL":"https:\/\/doi.org\/10.3390\/ijms27198564","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]}}}